Description Results NMA

pulmonary embolims (symptomatic and asymptomatic) 0.22 [0.05; 0.93]

death 1.00 [0.29; 3.40]

major bleeding 1.50 [0.54; 4.14]

asymptomatic pulmonary embolism 0.00 [0.00; NaN]

symptomatic pulmonary embolism 0.40 [0.08; 2.04]

caval filter (n=200)

vs.

no filter (n=200)

2x2 factorial design also comparing LMWH vs unfractionated heparin

open

Parallel groups

Sample size: 200/200

Primary endpoint: none

FU duration: 12 days and 2 years